FDA Approves AOP Health’s Rapiblyk for Atrial Fibrillation and Atrial Flutter
Approval was based on the combined results from five studies of adults with supraventricular tachycardia.
October 22, 2026
Approval was based on the combined results from five studies of adults with supraventricular tachycardia.